Ekso Financial Statements From 2010 to 2026

EKSO Stock  USD 8.02  0.10  1.26%   
Ekso Bionics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ekso Bionics' valuation are provided below:
Gross Profit
7.9 M
Profit Margin
(0.71)
Market Capitalization
28.2 M
Enterprise Value Revenue
2.2556
Revenue
14.7 M
We have found one hundred twenty available fundamental signals for Ekso Bionics Holdings, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify Ekso Bionics' prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 27th of January 2026, Market Cap is likely to drop to about 252.8 M. In addition to that, Enterprise Value is likely to drop to about 238.5 M

Ekso Bionics Total Revenue

11.51 Million

Check Ekso Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ekso Bionics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 260.2 K or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 11.24, Dividend Yield of 0.0076 or PTB Ratio of 15.86. Ekso financial statements analysis is a perfect complement when working with Ekso Bionics Valuation or Volatility modules.
  
Build AI portfolio with Ekso Stock
Check out the analysis of Ekso Bionics Correlation against competitors.

Ekso Bionics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets26.2 M30.6 M23 M
Slightly volatile
Short and Long Term Debt Total5.1 M6.9 M4.5 M
Slightly volatile
Total Current Liabilities6.7 M8.7 M5.9 M
Slightly volatile
Total Stockholder Equity13.7 M14.6 M11.2 M
Slightly volatile
Property Plant And Equipment Net2.6 M2.7 M2.3 M
Slightly volatile
Accounts Payable2.3 M1.8 MM
Slightly volatile
Cash7.1 M7.5 M12.4 M
Pretty Stable
Non Current Assets TotalMM4.6 M
Slightly volatile
Cash And Short Term Investments7.1 M7.5 M12.4 M
Pretty Stable
Common Stock Total Equity8.7 K9.2 K30.6 K
Pretty Stable
Liabilities And Stockholders Equity26.2 M30.6 M23 M
Slightly volatile
Non Current Liabilities Total7.4 M7.4 MM
Slightly volatile
Inventory2.7 M5.3 M2.5 M
Slightly volatile
Other Stockholder Equity177.8 M301.5 M152.4 M
Slightly volatile
Total Liabilities13.6 M16 M11.9 M
Slightly volatile
Total Current Assets22 M21.7 M19.1 M
Slightly volatile
Short Term Debt1.1 M1.9 MM
Slightly volatile
Common Stock32.1 K19.8 K34.4 K
Very volatile
Common Stock Shares Outstanding24.3 M23.2 M7.6 M
Slightly volatile
Net Receivables8.7 M8.3 M3.6 M
Slightly volatile
Other Current Assets769.4 K486.9 K1.1 M
Slightly volatile
Other Liabilities1.2 M1.3 MM
Slightly volatile
Net Tangible Assets15.5 M22.8 M17.4 M
Very volatile
Long Term Debt3.8 M4.4 M2.8 M
Slightly volatile
Long Term Debt Total11 M10.5 M5.4 M
Slightly volatile
Capital Surpluse165 M235 M155.6 M
Slightly volatile
Deferred Long Term Liabilities30.8 K32.4 K1.4 M
Slightly volatile
Property Plant And Equipment Gross3.3 M6.6 MM
Slightly volatile
Short and Long Term Debt1.7 M1.1 M1.5 M
Slightly volatile
Intangible Assets2.8 M5.3 M2.8 M
Slightly volatile
Property Plant Equipment2.6 M4.6 M2.6 M
Slightly volatile
Non Current Liabilities Other154.8 K162.9 K552.4 K
Slightly volatile
Deferred Long Term Asset ChargesM2.3 M2.5 M
Slightly volatile
Capital Lease Obligations693.7 KM453.2 K
Slightly volatile
Net Invested Capital22 M20.5 M23.6 M
Slightly volatile
Net Working Capital14.1 M10.2 M20.3 M
Slightly volatile
Capital Stock25.3 K19.8 K45.3 K
Slightly volatile

Ekso Bionics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.1 M1.8 M989.4 K
Slightly volatile
Selling General Administrative9.2 M10.1 MM
Slightly volatile
Selling And Marketing Expenses9.6 M8.4 M8.5 M
Slightly volatile
Total Revenue11.5 M20.6 M10.2 M
Slightly volatile
Gross Profit11.5 M10.9 M4.7 M
Slightly volatile
Other Operating Expenses30.1 M32.6 M26.6 M
Slightly volatile
Research Development4.1 M3.5 M5.1 M
Slightly volatile
Cost Of Revenue6.7 M9.7 M5.9 M
Slightly volatile
Total Operating Expenses23.6 M23 M20.9 M
Slightly volatile
Non Recurring482 K389.7 K539.7 K
Slightly volatile
Reconciled Depreciation889.4 K1.4 M1.4 M
Slightly volatile

Ekso Bionics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow16.2 M9.9 M12.8 M
Slightly volatile
Total Cash From Financing Activities12.3 MM12.9 M
Very volatile
End Period Cash Flow7.1 M7.5 M12.4 M
Pretty Stable
Stock Based Compensation2.6 M1.9 M2.1 M
Slightly volatile
Depreciation1.3 M1.8 M1.1 M
Slightly volatile
Dividends Paid8.3 M9.3 M10.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio11.2411.84149
Slightly volatile
Dividend Yield0.00760.00860.0094
Slightly volatile
PTB Ratio15.8616.7311.8 K
Slightly volatile
Days Sales Outstanding91.5133107
Slightly volatile
Book Value Per Share0.690.724.6668
Slightly volatile
Average Payables1.3 M1.5 M1.6 M
Slightly volatile
Stock Based Compensation To Revenue0.09930.10.2041
Slightly volatile
Capex To Depreciation0.02510.02650.7766
Slightly volatile
PB Ratio15.8616.7311.8 K
Slightly volatile
EV To Sales11.2111.8148
Slightly volatile
Inventory Turnover3.692.123.4814
Slightly volatile
Days Of Inventory On Hand118178140
Slightly volatile
Payables Turnover5.124.883.1636
Slightly volatile
Sales General And Administrative To Revenue0.960.560.9331
Slightly volatile
Average Inventory536.1 K603.2 K658.4 K
Slightly volatile
Research And Ddevelopement To Revenue0.240.250.7315
Slightly volatile
Capex To Revenue0.00230.00240.1037
Slightly volatile
Cash Per Share0.350.376.2348
Slightly volatile
Days Payables Outstanding73.5577.42140
Slightly volatile
Income Quality0.730.780.8734
Very volatile
Intangibles To Total Assets0.180.170.0757
Slightly volatile
Net Debt To EBITDA0.04610.04860.6207
Very volatile
Current Ratio2.492.252.9811
Pretty Stable
Tangible Book Value Per Share0.420.444.4012
Slightly volatile
Receivables Turnover3.992.853.877
Slightly volatile
Shareholders Equity Per Share0.690.724.6668
Slightly volatile
Debt To Equity0.510.541.6893
Slightly volatile
Capex Per Share0.0020.00210.5921
Slightly volatile
Revenue Per Share0.971.024.7228
Slightly volatile
Interest Debt Per Share0.340.360.9017
Very volatile
Debt To Assets0.220.260.2044
Pretty Stable
Operating Cycle203311239
Slightly volatile
Price Book Value Ratio15.8616.7311.8 K
Slightly volatile
Days Of Payables Outstanding73.5577.42140
Slightly volatile
Ebt Per Ebit1.141.251.1728
Slightly volatile
Effective Tax Rate0.03520.03960.0432
Slightly volatile
Company Equity Multiplier2.292.415.2728
Slightly volatile
Long Term Debt To Capitalization0.40.270.383
Slightly volatile
Total Debt To Capitalization0.390.370.364
Pretty Stable
Debt Equity Ratio0.510.541.6893
Slightly volatile
Cash Ratio0.940.992.1441
Pretty Stable
Days Of Inventory Outstanding118178140
Slightly volatile
Days Of Sales Outstanding91.5133107
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.151.0568
Pretty Stable
Price To Book Ratio15.8616.7311.8 K
Slightly volatile
Fixed Asset Turnover3.666.824.3644
Slightly volatile
Debt Ratio0.220.260.2044
Pretty Stable
Price Sales Ratio11.2411.84149
Slightly volatile
Asset Turnover0.730.7744.7414
Slightly volatile
Gross Profit Margin0.30.480.3522
Slightly volatile
Price Fair Value15.8616.7311.8 K
Slightly volatile

Ekso Bionics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap252.8 M266.1 M647.5 M
Slightly volatile
Enterprise Value238.5 M251.1 M635 M
Slightly volatile

Ekso Fundamental Market Drivers

Ekso Upcoming Events

26th of March 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ekso Bionics Financial Statements

Ekso Bionics investors utilize fundamental indicators, such as revenue or net income, to predict how Ekso Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.2 M1.4 M
Total Revenue20.6 M11.5 M
Cost Of Revenue9.7 M6.7 M
Stock Based Compensation To Revenue 0.10  0.10 
Sales General And Administrative To Revenue 0.56  0.96 
Research And Ddevelopement To Revenue 0.25  0.24 
Revenue Per Share 1.02  0.97 
Ebit Per Revenue(0.53)(0.55)

Pair Trading with Ekso Bionics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.

Moving against Ekso Stock

  0.78ELAB Elevai Labs CommonPairCorr
  0.66WOK WORK Medical TechnologyPairCorr
  0.65688656 HOB Biotech GroupPairCorr
  0.51300981 Zhonghong Pulin MedicalPairCorr
  0.44688198 Beijing Balance MedicalPairCorr
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out the analysis of Ekso Bionics Correlation against competitors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.38)
Revenue Per Share
7.246
Quarterly Revenue Growth
0.024
Return On Assets
(0.27)
Return On Equity
(0.85)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.